These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31741178)

  • 41. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].
    Grolleau A; Cougnard A; Parrot M; Kalmi E; Desage A; Misdrahi D; Brun-Rousseau H; Verdoux H
    Encephale; 2007; 33(3 Pt 1):326-31. PubMed ID: 17675930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sex, ethnicity, and antipsychotic medication use in patients with psychosis.
    Arnold LM; Strakowski SM; Schwiers ML; Amicone J; Fleck DE; Corey KB; Farrow JE
    Schizophr Res; 2004 Feb; 66(2-3):169-75. PubMed ID: 15061250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discontinuing antipsychotic treatment after a first-episode of psychosis: Who, when and how?
    Emsley R
    Schizophr Res; 2018 Jul; 197():59-60. PubMed ID: 29129505
    [No Abstract]   [Full Text] [Related]  

  • 47. The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis.
    Faber G; Smid HG; Van Gool AR; Wiersma D; Van Den Bosch RJ
    Eur Psychiatry; 2012 May; 27(4):275-80. PubMed ID: 21561741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pimozide for schizophrenia or related psychoses.
    Mothi M; Sampson S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-acting injectable antipsychotics in the elderly: guidelines for effective use.
    Masand PS; Gupta S
    Drugs Aging; 2003; 20(15):1099-110. PubMed ID: 14651433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visual working memory deterioration preceding relapse in psychosis.
    Hui CL; Li YK; Li AW; Lee EH; Chang WC; Chan SK; Lam SY; Thornton AE; Sham P; Honer WG; Chen EY
    Psychol Med; 2016 Aug; 46(11):2435-44. PubMed ID: 27305830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
    Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
    Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The evaluation and treatment of first-episode psychosis.
    Sheitman BB; Lee H; Strous R; Lieberman JA
    Schizophr Bull; 1997; 23(4):653-61. PubMed ID: 9366001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
    Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Optimal Antipsychotic Dose and Dosing Interval in the Treatment of Schizophrenia].
    Takeuchi H
    Seishin Shinkeigaku Zasshi; 2015; 117(7):562-7. PubMed ID: 26552322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.
    Iyo M; Tadokoro S; Kanahara N; Hashimoto T; Niitsu T; Watanabe H; Hashimoto K
    J Clin Psychopharmacol; 2013 Jun; 33(3):398-404. PubMed ID: 23609386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).
    Brugnoli R; Rapinesi C; Kotzalidis GD; Marcellusi A; Mennini FS; De Filippis S; Carrus D; Ballerini A; Francomano A; Ducci G; Del Casale A; Girardi P
    Riv Psichiatr; 2016; 51(2):47-59. PubMed ID: 27183509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of typical and atypical antipsychotic medication on hostility in patients with psychosis-spectrum disorders: a review and meta-analysis.
    Faay MDM; Czobor P; Sommer IEC
    Neuropsychopharmacology; 2018 Nov; 43(12):2340-2349. PubMed ID: 30093698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in pharmacological treatment of psychosis in late life.
    Chan WC; Lam LC; Chen EY
    Curr Opin Psychiatry; 2011 Nov; 24(6):455-60. PubMed ID: 21799414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Systematic Review of the Need for Guideline Recommendations; Slow Tapering vs. Maintenance Dose in Long-Term Antipsychotic Treatment: 2022.
    Potla S; Al Qabandi Y; Nandula SA; Boddepalli CS; Gutlapalli SD; Lavu VK; Abdelwahab Mohamed Abdelwahab R; Huang R; Hamid P
    Cureus; 2023 Feb; 15(2):e34746. PubMed ID: 36777974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.
    Harrow M; Jobe TH; Faull RN
    Psychol Med; 2014 Oct; 44(14):3007-16. PubMed ID: 25066792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.